Results

Total Results: 14 records

Showing results for "atopic dermatitis".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
    October 01, 2016 - Allergy, Atopic Dermatitis, and Respiratory Conditions Additional outcomes newly included in the current … Atopic dermatitis/eczema: Four prenatal and three postnatal RCTs showed inconsistent effects of maternal … n-3 FA supplementation on the risk for atopic dermatitis/ eczema: Only one of the prenatal studies … maternal dietary intake or breast milk composition) and risk for atopic dermatitis/eczema. … biomarkers 4 RCTs Low RCTs: No significant (and inconsistent) effects on risk for atopic dermatitis
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/omega-3-maternity_research-protocol.pdf
    May 18, 2015 - dermatitis, allergies, and respiratory disorders, specifically looking at the risk for (or prevention … dermatitis • Allergies • Respiratory illness – What are the associations of the n-3 FA content or …  dermatitis • Allergies • Respiratory  illness EFFECT  MODIFIER E.g.,  omega-­‐6/oega-­‐ 3 … dermatitis, allergy, respiratory conditions) of mothers whose n-3 exposures were monitored during … dermatitis" OR (congenital AND ("vision disorder")) OR "learning disorder" OR "learning disorders"
  3. effectivehealthcare.ahrq.gov/products/omega-3-maternity/research-protocol
    May 18, 2015 - dermatitis, allergies, and respiratory disorders, specifically looking at the risk for (or prevention … dermatitis Allergies Respiratory illness What are the associations of the n-3 FA content or … full term infants with and without family history of respiratory conditions (for outcomes related to atopicdermatitis'/de OR 'autism'/exp OR 'hypersensitivity'/exp #10 retrolental AND fibroplas* OR retinopathy … dermatitis" OR (congenital AND ("vision disorder")) OR "learning disorder" OR "learning disorders" OR
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-benefits-infants-children-key-questions.pdf
    January 01, 2018 - o childhood cancer (including leukemias), o Type I and II diabetes, o Allergic triad: asthma, atopicdermatitis, allergic rhinitis o Cardiovascular disease (including hypertension), o Hyperlipidemia
  5. effectivehealthcare.ahrq.gov/products/psoriasis-chronic/research-protocol
    September 27, 2011 - Exposure to UVB radiation ranging from 254 to 313 nm ‡ UVB phototherapy for psoriasis, vitiligo, atopicdermatitis, and leukoderma NB-UVB Exposure to UVB radiation ranging from 311 to 313 nm DuaLight … UVB phototherapy for psoriasis, vitiligo, atopic dermatitis, and leukoderma PUVA Methoxsalen (8-MOP … UVB phototherapy for psoriasis, vitiligo, atopic dermatitis, and leukoderma Analytic Framework
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - Exposure to UVB radiation ranging from 254 to 313 nm ‡ UVB phototherapy for psoriasis, vitiligo, atopicdermatitis, and leukoderma NB-UVB Exposure to UVB radiation ranging from 311 to 313 nm • DuaLight … UVB phototherapy for psoriasis, vitiligo, atopic dermatitis, and leukoderma PUVA Methoxsalen (8-MOP … UVB phototherapy for psoriasis, vitiligo, atopic dermatitis, and leukoderma *Listed devices are
  7. effectivehealthcare.ahrq.gov/health-topics/eczema
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - HPV DT, TT, and aP Asthma Influenza Ataxia Varicella (as cerebellar ataxia) MMR DT,TT, aP Atopicdermatitis Below severity threshold Autism DT, TT, and aP MMR Autoimmune hepatitis Hepatitis A
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - HPV DT, TT, and aP Asthma Influenza Ataxia Varicella (as cerebellar ataxia) MMR DT,TT, aP Atopicdermatitis Below severity threshold Autism DT, TT, and aP MMR Autoimmune hepatitis Hepatitis A
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopicdermatitis in children: a double-blind, randomized, active- controlled study. … Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopicdermatitis: an 8-week, double-blind, randomized, placebo-controlled study.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
    January 01, 2010 - Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - Affairs Global Organization for EPA and DHA Omega-35 Noted errors in the text • The section on “AtopicDermatitis and Eczema” (page 204) states a total of ten observational studies were included, but there
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
    June 30, 2016 - Patient-centered, direct- access online care for management of atopic dermatitis: a randomized clinical
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
    December 01, 2017 - for other skin diseases such as psoriasis (The International Dermatology Outcome Measures)19 and atopicdermatitis (Harmonizing Outcome Measures for Eczema).20 Third, while more evidence is needed overall

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: